| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | Parent |
| ATC: | N05BA08 |
| UNII: | X015L14V0O |
Structure
| InChI Key | VMIYHDSEFNYJSL-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
Physicochemical Descriptors
| Property Name | Value |
|---|---|
| Molecular Formula | C14H10BrN3O |
| Molecular Weight | 316.16 |
| AlogP | 2.63 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 1.0 |
| Polar Surface Area | 54.35 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 19.0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| POSITIVE ALLOSTERIC MODULATOR | GABA receptor alpha-2 subunit positive allosteric modulator |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Dementia | 3 | D003704 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Schizophrenia | 3 | D012559 | ClinicalTrials |
Related Entries
Scaffolds
Environmental Impact
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 1812-30-2 |
| ChEBI | 31302 |
| ChEMBL | CHEMBL277062 |
| DrugBank | DB01558 |
| DrugCentral | 399 |
| EPA CompTox | DTXSID40171081 |
| FDA SRS | X015L14V0O |
| Human Metabolome Database | HMDB15511 |
| PharmGKB | PA10035 |
| PubChem | 2441 |
| SureChEMBL | SCHEMBL43933 |
| ZINC | ZINC000000001051 |
CONTENTS